MASLD is prevalent in T2DM patients, with a 65% occurrence rate, and poses a higher risk for severe liver diseases. The study analyzed 3,836 T2DM patients, identifying key predictors like BMI, ...
Highlights from dyslipidemia research presented at the American College of Cardiology Scientific Sessions 2026, focusing on ...
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results